Geovax Labs logo

Geovax Labs Share Price (NASDAQ: GOVX)

$0.75

0.01

(1.35%)

Last updated on

Check the interactive Geovax Labs Stock chart to analyse performance

Geovax Labs stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.71
    Today's High:$0.75

    Day's Volatility :5.25%

  • 52 Weeks Low:$0.43
    52 Weeks High:$5.28

    52 Weeks Volatility :91.86%

Geovax Labs Stock Returns

PeriodGeovax Labs IncSector (Health Care)Index (Russel 2000)
3 Months
-28.65%
3.6%
0.0%
6 Months
-50.86%
-7.7%
0.0%
1 Year
-83.58%
-12.6%
0.0%
3 Years
-95.66%
10.2%
-4.1%

Geovax Labs Inc Key Stats

Check Geovax Labs key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.74
Open
$0.748
Today's High
$0.75
Today's Low
$0.7106
Market Capitalization
$19.2M
Today's Volume
$276.8K
52 Week High
$5.28
52 Week Low
$0.43
Revenue TTM
$6.1M
EBITDA
$-24.9M
Earnings Per Share (EPS)
$-0.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-9690.24%

Stock Returns calculator for Geovax Labs Stock including INR - Dollar returns

The Geovax Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Geovax Labs investment value today

Current value as on today

₹21,877

Returns

₹78,123

(-78.12%)

Returns from Geovax Labs Stock

₹83,407 (-83.41%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Geovax Labs Stock

-57%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Geovax Labs Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Geovax Labs Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    0.45%

  • Morgan Stanley - Brokerage Accounts

    0.40%

  • Geode Capital Management, LLC

    0.38%

  • UBS Group AG

    0.36%

  • BlackRock Inc

    0.11%

  • Jane Street Group LLC

    0.10%

Analyst Recommendation on Geovax Labs Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Geovax Labs(by analysts ranked 0 to 5 stars)

Geovax Labs Share Price Target

What analysts predicted

Upside of 1283.33%

Target:

$10.38

Current:

$0.75

Geovax Labs share price target is $10.38, a slight Upside of 1283.33% compared to current price of $0.75 as per analysts' prediction.

Geovax Labs Stock Insights

  • Price Movement

    In the last 3 months, GOVX stock has moved down by -27.3%
  • GOVX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 153.9%
  • GOVX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 211.8%
  • Price to Sales

    ForGOVX every $1 of sales, investors are willing to pay $1.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Geovax Labs Technicals Summary

Sell

Neutral

Buy

Geovax Labs is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Geovax Labs Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Geovax Labs Inc logo
2.39%
-50.86%
-83.58%
-95.66%
-98.32%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Geovax Labs Inc

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Organization
Geovax Labs
Employees
17
CEO
Mr. David Alan Dodd
Industry
Biotechnology

Key Management of Geovax Labs Inc

NameTitle
Mr. David Alan Dodd
Chairman, President & CEO
Dr. Mark J. Newman Ph.D.
Chief Scientific Officer
Dr. Kelly T. McKee Jr., M.D., M.P.H.
Chief Medical Officer
Dr. Harriet Latham Robinson Ph.D.
Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board
Mr. Mark W. Reynolds CPA
CFO & Corporate Secretary
Mr. Thomas O'Brien
Vice President of Quality Systems & Compliance
Mr. Jeffrey Welch
Head of Process Development & Manufacturing Operations
Dr. John W. Sharkey Ph.D.
Vice President of Business Development

Important FAQs about investing in GOVX Stock from India :

What is Geovax Labs share price today?

Geovax Labs share price today is $0.75 as on at the close of the market. Geovax Labs share today touched a day high of $0.75 and a low of $0.71.

What is the 52 week high and 52 week low for Geovax Labs share?

Geovax Labs share touched a 52 week high of $5.28 and a 52 week low of $0.43. Geovax Labs stock price today i.e. is closed at $0.75, lower by 85.8% versus the 52 week high.

How to invest in Geovax Labs Stock (GOVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Geovax Labs on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Geovax Labs Shares that will get you 2.0000 shares as per Geovax Labs share price of $0.75 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Geovax Labs Stock (GOVX) from India?

Indian investors can start investing in Geovax Labs (GOVX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Geovax Labs stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Geovax Labs share’s latest price of $0.75 as on August 30, 2025 at 1:29 am IST, you will get 13.3333 shares of Geovax Labs. Learn more about fractional shares .

What are the returns that Geovax Labs has given to Indian investors in the last 5 years?

Geovax Labs stock has given -98.32% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?